McCoy John A. Jr.'s Form 4 filing
Abbott Laboratories (ABT) · filed Mar 4, 2025
- Accession no.
- 0001415889-25-006768
- Filed
- Mar 4, 2025
- Trade date
- Feb 28-Mar 3, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $77.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McCoy John A. Jr.CIK 0001644207 | Officer (VICE PRESIDENT AND CONTROLLER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Common shares without par value | FTax withholdingDisposed | −1,096 | $135.87 | −$148,913.52 | 21,623 | Direct | |
| Mar 3, 2025 | Common shares without par value | SSaleDisposed | −562 | $138.17 | −$77,651.54 | 21,061 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.